The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 2, 2003, Pages 331-338

  Gauvreau, Gail M ^a   Becker, Allan B ^b   Boulet, Louis Philippe ^c   Chakir, Jamila ^c   Fick, Robert B ^d   Greene, William L ^d   Killian, Kieran J ^a   O'Byrne, Paul M ^a   Reid, John K ^e   Cockcroft, Donald W ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d GENENTECH INC   (United States)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Allergen inhalation challenge; Anti CD11a antibody; LFA 1; Sputum eosinophils

Indexed keywords

ALLERGEN; CD11A ANTIBODY; EFALIZUMAB; IMMUNOGLOBULIN G2; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; AREA UNDER THE CURVE; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; FLU LIKE SYNDROME; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZATION; RESPIRATORY TRACT INFLAMMATION; STATISTICAL ANALYSIS;

EID: 0042530461     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1689     Document Type: Article

References (45)

1. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic response. Am Rev Respir Dis 1987;136:740-56.
2. Cartier A, Thomson NC, Frith PA, Roberts R. Hargreave FE. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982;70:170-7.
3. Crimi E, Chiaramondia M, Milanese M, Rossi GA, Brusasco V. Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis 1991;144:1282-6.
4. Aalbers R, Kauffman HF, Vrugt B, Keoter GH, De Monchy JGR. Allergen-induced recruitment of inflammatory cells in lavage 3 and 24h after challenge in allergic asthmatic lungs. Chest 1993;103:1178-84.
5. Pin I, Freitag AP, O'Byrne PM, Girgis-Gabardo A, Watson RM, Dolovich J, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992;145:1265-9.
6. Gauvreau GM, Lee JM, Watson RM, Irani AA, Schwartz LB, O'Byrne PM. Increased numbers of both airway basophils and mast cells after allergen inhalation challenge in atopic asthmatics. Am J Respir Crit Care Med 2000;161:1473-8.
7. Dente FL, Bancalari L, Bacci E, Bartoli ML, Carnevali S, Cianchetti S, et al. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax 1999;54:622-4.
8. Cockcroft DW, O'Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995;96:44-9.
9. Gauvreau GM, Jordana M, Watson RM, Cockcroft DW, O'Byrne PM. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med 1997;156:1738-45.
10. Gauvreau GM, Doctor JR, Watson RM, Jordana M, O'Byrne PM. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996;154:1267-71.
11. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion moleculee-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988;107:321-31.
12. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution, structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTS-target interactions. J Immunol 1983;131:611-6.
13. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987;5:223-52.
14. Gottlieb A, Krueger JG, Bright R, Ling M, Lebwohl M, Kang S, et al. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 2000;42:428-35.
15. Laberge S, Rabb H, Issekutz TB, Martin JG. Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. Am J Respir Crit Care Med 1995;151:822-9.
16. Rabb HA, Olivenstein R, Issekutz TB. Renzi PM, Martin JG. The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. Am J Respir Crit Care Med 1994;149:1186-91.
17. Aldrich MC, Li C, Tumas D, Tepper JS. Aerosol administration of αCD11a reduces established allergic inflammation. Am J Respir Crit Care Med 2001;163:A594.
18. Whitcup SM, Chan C-C, Kozhich AT, Magone MT. Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis. Clin Immunol 1999;93:107-13.
19. Cockcroft DW. Measure of airway responsiveness to inhaled histamine or methacholine: method of continuous aerosol generation and tidal breathing inhalation. In: Hargreave FE, Woolcock AJ, editors. Airway responsiveness: measurement and interpretation. Mississauga (ON):Astra Pharmaceuticals Canada Ltd; 1985. p. 22-8.
20. Cockcroft DW, Murdock KY, Kirby J, Hargreave FE. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987;135:264-7.
21. Pizzichini E, Pizzichini MMM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-17.
22. Snedecor GW, Cochran WG. Statistical methods. 8th ed. Ames (IA): Iowa State University Press; 1989.
23. Wood LJ, Sehmi R, Gauvreau GM, Watson RM, Foley R, Denburg JA, et al. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects. Am J Respir Crit Care Med 1999;159:1457-63.
24. Issekutz TB. Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation. Am J Pathol 1993;143:1286-93.
25. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule I/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994;179:1145-54.
26. Issekutz AC, Issekutz TB. The contribution of LFA-1 (CD11a/CD18) and MAC-1 (CD11b/CD18) to the in vivo migration of polymorphonuclear leucocytes to inflammatory reactions in the rat. Immunology 1992;76:655-61.
27. Koarai A, Ichinose M, Ishigaki-Suzuki S, Yamagata S, Sugiura H, Sakurai E, et al. Disruption of L-histidine decarboxylase reduces airway eosinophilia but not hyperresponsiveness. Am J Respir Crit Care Med 2003;167:758-63.
28. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2114-6.
29. Haselden BM, Larche M, Meng Q, Shirley K, Dworski R, Kaplan AP, et al. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or TH2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol 2001;108:394-401.
30. Louis R, Sele J, Henket M, Cataldo D, Bettiol J, Seiden L, et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy 2002;57:907-12.
31. Gronke L, Kanniess F, Holz O, Jorres RA, Magnussen H. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 2002;32:57-63.
32. Obase Y, Shimoda T, Mitsuta K, Matsuo N, Matsuse H, Kohno S. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum. Ann Allergy Asthma Immunol 2001;86:304-10.
33. Bauer RJ, Dedrick RJ, White ML, Murray MJ, Garovoy MR. Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis. J Pharmacokinet Biopharm 1999;27:397-420.
34. Leonardi C, Gottlieb AB, Miller B, Tashjian D, Pariser D, Shapiro W, et al. Anti-CD11a: 12 week trial of subcutaneous administration in patients with moderate to severe plaque psoriasis. J Allergy Clin Immunol 2001;107:S309.
35. Krueger J, Gottlieb A, Miller B, Dedrick R, Garovoy M, Walicke P. Anti-CD11a treatment for psoriasis concurrently increases circulating T-cells and decreases plaque T-cells, consistent with inhibition of cutaneous T-cell trafficking [abstract]. J Invest Dermatol 2000;115:333.
36. Poston RS, Robbins RC, Chan B, Simms P, Presta L, Jarkieu P, et al. Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients. Transplantation 2000;69:2005-13.
37. Bowles MJ, Pockley AG, Wood RFM. Effect of anti-LFA-1 monoclonal antibody on rat small bowel allograft survival and circulating leukocyte populations. Transpl Immunol 2000;8:75-80.
38. De Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991;174:253-67.
39. Pals ST, Otter A, Miedema F, Kabel P, Keizer GD, Scheper RJ, et al. Evidence that leukocyte function-associated antigen-1 is involved in recirculation and homing of human lymphocytes via high endothelial venules. J Immunol 1988;140:1851-3.
40. Klemm A, Tschernig T, Ermert L, et al. Blockade of leucocyte function-associated antigen-1 (LFA-1) decreases lymphocyte trapping in the normal pulmonary vasculature: studies in the isolated buffer-perfused rat lung. Clin Exp Immunol 2000;212:375-83.
41. Faveeuw C, Di Mauro ME, Price AA, Ager A. Roles of alpha(4) integrins/VCAM-1 and LFA-1/ICAM-1 in the binding and transendothelial migration of T lymphocytes and T lymphoblasts across high endothelial venules. Int Immunol 2000;12:241-51.
42. Murphy A, Long A, Volkov Y, Kelleher D. Cross-linking of LFA-1 induces secretion of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta with consequent directed migration of activated lymphocytes. Eur J Immunol 2000;30:3006-11.
43. Lantero S, Alessandri G, Spallarossa D, Scarso L, Rossi GA. LFA-1 expression by blood eosinophils is increased in atopic asthmatic children and is involved in eosinophil locomotion. Eur Respir J 1998;12:1094-8.
44. Lantero S, Spallarossa D, Silvestri M, Sabatini F, Scarso L, Crimi E, et al. In allergic asthma experimental exposure to allergens is associated with depletion of blood eosinophils overexpressing LFA-1. Allergy 2002;57:1036-43.
45. Pesce G, Ciprandi G, Buscaglia S, Fiorino N, Salmaso C, Riccio AM, et al. Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy. Allergy Immunol 2001;125:160-3.